Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

456

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

exenatide

subcutaneous injection, 5 mcg, twice a day for 4 weeks (transition period), then 10 mcg twice a day till study termination

Trial Locations (60)

Unknown

Research Site, Birmingham

Research Site, Anaheim

Research Site, Bellflower

Research Site, Burlingame

Research Site, Chula Vista

Research Site, Concord

Research Site, Encino

Research Site, Fremont

Research Site, La Jolla

Research Site, Los Gatos

Research Site, Moreno Valley

Research Site, Redwood City

Research Site, San Mateo

Research Site, Walnut Creek

Research Site, Aurora

Research Site, Denver

Research Site, Gainesville

Research Site, Jacksonville

Research Site, Largo

Research Site, Maitland

Research Site, Miami

Research Site, Ocala

Research Site, Blairsville

Research Site, Honolulu

Research Site, Chicago

Research Site, Indianapolis

Research Site, Lexington

Research Site, Covington

Research Site, New Orleans

Research Site, Slidell

Research Site, Detroit

Research Site, Edina

Research Site, Minneapolis

Research Site, Gulfport

Research Site, Picayune

Research Site, Chesterfield

Research Site, St Louis

Research Site, Butte

Research Site, Las Vegas

Research Site, New York

Research Site, Rochester

Research Site, Cary

Research Site, Durham

Research Site, Columbus

Research Site, Marion

Research Site, Maumee

Research Site, Mentor

Research Site, Clinton

Research Site, Oklahoma City

Research Site, Medford

Research Site, Portland

Research Site, Camp Hill

Research Site, Philadelphia

Research Site, Dallas

Research Site, Houston

Research Site, Midland

Research Site, San Antonio

Research Site, Salt Lake City

Research Site, Olympia

Research Site, Spokane

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY